Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × OTHER × Transportation × Clear all

Phase

Status

Recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lung Neoplasms 1 Behavior 1

Interventions

Cyclophosphamide 795 Radiotherapy 718 Cisplatin 621 Gemcitabine 548 Carboplatin 511 Docetaxel 508 Paclitaxel 496 Bevacizumab 478 Fluorouracil 424 Rituximab 382 Capecitabine 378 Oxaliplatin 377 Surveys and Questionnaires 372 Doxorubicin 361 Dexamethasone 361 Etoposide 344 Irinotecan 325 Filgrastim 318 Cytarabine 314 pembrolizumab 265 Leucovorin 255 Melphalan 251 Magnetic Resonance Spectroscopy 242 fludarabine phosphate 241 Nivolumab 238 Blood Specimen Collection 233 Peripheral Blood Stem Cell Transplantation 232 Lenalidomide 231 Bortezomib 225 Methotrexate 223

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06207435 2025-09-02

LCS

Abramson Cancer Center at Penn Medicine

Phase NA Completed

242 enrolled 8 charts

Behavior, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡